Schwab Charles Investment Management Inc. boosted its holdings in shares of Cantel Medical Corp. (NYSE:CMD) by 4.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 198,741 shares of the company’s stock after acquiring an additional 9,021 shares during the period. Schwab Charles Investment Management Inc. owned 0.48% of Cantel Medical worth $18,716,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of CMD. BlackRock Inc. purchased a new position in Cantel Medical during the second quarter valued at approximately $376,271,000. Vanguard Group Inc. purchased a new position in shares of Cantel Medical in the second quarter worth $246,860,000. Neuberger Berman Group LLC purchased a new position in shares of Cantel Medical in the second quarter worth $96,236,000. Dimensional Fund Advisors LP purchased a new position in shares of Cantel Medical in the second quarter worth $75,756,000. Finally, Wells Fargo & Company MN purchased a new position in shares of Cantel Medical in the second quarter worth $75,715,000. 85.20% of the stock is owned by institutional investors.
Cantel Medical Corp. (CMD) traded up $2.53 during trading on Thursday, reaching $108.30. 94,195 shares of the company were exchanged, compared to its average volume of 153,525. The stock has a market capitalization of $4,530.00, a P/E ratio of 59.83 and a beta of 1.25. The company has a current ratio of 2.44, a quick ratio of 1.48 and a debt-to-equity ratio of 0.31. Cantel Medical Corp. has a 52 week low of $69.21 and a 52 week high of $108.67.
In other news, Director George L. Fotiades sold 6,000 shares of the company’s stock in a transaction dated Friday, October 13th. The shares were sold at an average price of $95.23, for a total value of $571,380.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Eric W. Nodiff sold 2,868 shares of the company’s stock in a transaction dated Friday, October 20th. The stock was sold at an average price of $97.55, for a total transaction of $279,773.40. Following the completion of the transaction, the executive vice president now owns 39,102 shares in the company, valued at $3,814,400.10. The disclosure for this sale can be found here. 12.30% of the stock is owned by corporate insiders.
Cantel Medical Company Profile
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.